33 related articles for article (PubMed ID: 28687025)
1. Prognostic Implications of Endoscopic Obstruction in Patients with Pathological Stage II Colon Cancers: a Single-Center Retrospective Cohort Study.
Mo TW; Zhang ZJ; Shi YQ; Xiang HD; Chen YL; Chen ZX; Hu JC; He XW
J Gastrointest Surg; 2023 Jan; 27(1):141-151. PubMed ID: 36352061
[TBL] [Abstract][Full Text] [Related]
2. Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor-stroma ratio in colon cancer.
Polack M; Smit MA; van Pelt GW; Roodvoets AGH; Meershoek-Klein Kranenbarg E; Putter H; Gelderblom H; Crobach ASLP; Terpstra V; Petrushevska G; Gašljević G; Kjær-Frifeldt S; de Cuba EMV; Bulkmans NWJ; Vink GR; Al Dieri R; Tollenaar RAEM; van Krieken JHJM; Mesker WE;
ESMO Open; 2024 Apr; 9(4):102988. PubMed ID: 38613913
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer.
Catalano V; Loupakis F; Graziano F; Bisonni R; Torresi U; Vincenzi B; Mari D; Giordani P; Alessandroni P; Salvatore L; Fornaro L; Santini D; Baldelli AM; Rossi D; Giustini L; Silva RR; Falcone A; D'Emidio S; Rocchi M; Luzi Fedeli S
Ann Oncol; 2012 Jan; 23(1):135-141. PubMed ID: 21531784
[TBL] [Abstract][Full Text] [Related]
4. Colonoscopy following the positron emission tomography/computed tomography scan in patients with incidental colorectal uptake: what is the most effective management?
Duzkoylu Y; Kılavuz H; Demircioglu MK; Arıkan S; Sarı S
Rev Assoc Med Bras (1992); 2023; 69(9):e20230302. PubMed ID: 37729363
[TBL] [Abstract][Full Text] [Related]
5. Beneficial implications of adjuvant chemotherapy for stage IB lung adenocarcinoma exhibiting elevated SUVmax in FDG-PET/CT: a retrospective study from a single center.
Huang M; Liu B; Li X; Li N; Yang X; Wang Y; Zhang S; Lu F; Li S; Yan S; Wu N
Front Oncol; 2024; 14():1367200. PubMed ID: 38529383
[TBL] [Abstract][Full Text] [Related]
6. Combining pathological risk factors and T, N staging to optimize the assessment for risk stratification and prognostication in low-risk stage III colon cancer.
Xian ZY; Song YW; Zhang ZJ; Gan YG; Chen YL; Hu T; Wen XF; Mo TW; He XW
World J Surg Oncol; 2024 Jan; 22(1):10. PubMed ID: 38178080
[TBL] [Abstract][Full Text] [Related]
7. Staging Chest CT in Patients With Early-Stage Colon Cancer: Analysis of Impact on Survival Using Inverse Probability Weighting and Causal Diagram.
Lee S; Lee KH; Park JH; Kim HY; Choi Y; Lee KH
AJR Am J Roentgenol; 2023 Aug; 221(2):184-195. PubMed ID: 37095662
[No Abstract] [Full Text] [Related]
8. Is there no need to discuss adjuvant chemotherapy in stage II colon cancer patients with high tumor budding and lymphovascular invasion?
Zenger S; Gurbuz B; Can U; Erginoz E; Ozata IH; Yilmaz SP; Taskin OC; Peker O; Adsay V; Balik E; Bugra D
Langenbecks Arch Surg; 2023 Mar; 408(1):127. PubMed ID: 36973561
[TBL] [Abstract][Full Text] [Related]
9. Collaboration Between Surgeons and Medical Oncologists and Outcomes for Patients With Stage III Colon Cancer.
Hussain T; Chang HY; Veenstra CM; Pollack CE
J Oncol Pract; 2015 May; 11(3):e388-97. PubMed ID: 25873063
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant Chemotherapy for Colon Cancer.
Hoehn RS; Smith JJ
Dis Colon Rectum; 2019 Mar; 62(3):274-278. PubMed ID: 30741766
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of patients via colonoscopy who underwent positron emission tomography/computerized tomography due to colon involvement.
Ekmen MÖ; Aksoy EK
Rev Assoc Med Bras (1992); 2023; 69(10):e20230409. PubMed ID: 37792869
[TBL] [Abstract][Full Text] [Related]
12. Venous invasion detectable only by elastic stain shows weak prognostic value in colon cancer.
Fei LYN; Patel SV; Popa T; Boudreau L; Caycedo-Marulanda A; Grin A; Wang T
Histopathology; 2024 May; 84(6):1038-1046. PubMed ID: 38253910
[TBL] [Abstract][Full Text] [Related]
13. Commentary: The Benefit of Positron Emission Tomography/Computed Tomography in Stage I and Stage II Melanomas with High-Risk DecisionDx-Melanoma Scores.
Garland-Kledzik M
J Clin Aesthet Dermatol; 2023 Dec; 16(12 Suppl 1):S4-S5. PubMed ID: 38124999
[No Abstract] [Full Text] [Related]
14. Prognostic Value of Serum Neutrophil to Lymphocyte Ratio and SUVmax in Stage I and II Colon Cancer.
Choi SJ; Park JS; Baik H; An MS; Bae KB; Lee SS
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3837-3844. PubMed ID: 38019241
[TBL] [Abstract][Full Text] [Related]
15. Relationship between CT signs and the expression of miR-146a in colon cancer.
Liu Z; Li Y; Luo Q
Oncol Lett; 2018 Nov; 16(5):6598-6602. PubMed ID: 30333890
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of positron emission tomography/computed tomography for adjuvant chemotherapy of colon cancer.
Baik H; Lee SM; Seo SH; An MS; Kim KH; Bae KB; Oh MK; Hong KH
ANZ J Surg; 2018 Jun; 88(6):587-591. PubMed ID: 28687025
[TBL] [Abstract][Full Text] [Related]
17. Tumor/normal esophagus ratio in (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for response and prognosis stratification after neoadjuvant chemotherapy for esophageal squamous cell carcinoma.
Izumi D; Yoshida N; Watanabe M; Shiraishi S; Ishimoto T; Kosumi K; Tokunaga R; Taki K; Higashi T; Harada K; Miyata T; Ida S; Imamura Y; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Yamashita Y; Baba H
J Gastroenterol; 2016 Aug; 51(8):788-95. PubMed ID: 26671045
[TBL] [Abstract][Full Text] [Related]
18. T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy.
An MS; Yoo JH; Kim KH; Bae KB; Choi CS; Hwang JW; Kim JH; Kim BM; Kang MS; Oh MK; Hong KH
World J Surg Oncol; 2015 Feb; 13():64. PubMed ID: 25889520
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.
André T; de Gramont A; Vernerey D; Chibaudel B; Bonnetain F; Tijeras-Raballand A; Scriva A; Hickish T; Tabernero J; Van Laethem JL; Banzi M; Maartense E; Shmueli E; Carlsson GU; Scheithauer W; Papamichael D; Möehler M; Landolfi S; Demetter P; Colote S; Tournigand C; Louvet C; Duval A; Fléjou JF; de Gramont A
J Clin Oncol; 2015 Dec; 33(35):4176-87. PubMed ID: 26527776
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
